Pharma business info

Shares of diabetes drug manufacturer Amylin Pharmaceuticals Inc. soared on April 23 accompanying a report the firm is reaching out to prospective buyers on a possible sale.

Sun Pharmaceutical Industries Ltd. has announced that USFDA has given nod for its Abbreviated New Drug Application for generic edition of Zyprexa, Olanzapine tabs USP, 2.5mg, 5mg, 7.5mg,10mg, 15mg and 20mg

Pfizer Pfizer is determined on throwing away noncore biz groups. AstraZeneca is intent on appending any small firm, which might bring returns.

The pharmaceutical business has lifted up fears over parts of US President US President Barack Obama’s fiscal 2013 financial plan, claiming that the proposals could resulted in considerable job losses in the division.

Drug maufacturer GlaxoSmithKline Pharmaceuticals stated that the continued expansion of specialty products and vaccines, novel product launches and taut expense control assisted perk up profits.

Scrip of Sun Pharmaceutical Industries on Feb 16 declined around 3%, as the company stated that that US-based Wyeth Pharmaceuticals has sought compensation worth $960 million in a patent clash.

DARA BioSciences has entered into an exclusive United States deal with Uman Pharma for commercial rights to gemcitabine, an anticancer agent.

Dilip Shanghvi, the originator of Sun Pharmaceutical Industries Ltd, has bought a 3% equity stake in Natco Pharma Ltd. Natco's finance head made this declaration today.

Watson Pharmaceuticals Inc. (WPI) has rolled out a generic edition of Teva Pharma's LoSeasonique oral contraceptive pill under a settlement with the drug manufacturer.

A multi million pound package of measures were sketched by the PM David Cameron to back up the UK’s life sciences business and endorse faster access to novel medications
for patients.

Ranbaxy Laboratories has introduced an official generic edition of Caduet in the United States, as part of a pact with Pfizer Inc.